New Clues About How Viruses and Immune Activation May Relate to Type 1 Diabetes

For years, scientists have suspected that enteroviruses—common viruses that spread through respiratory droplets and the digestive system—might trigger Type 1 diabetes in genetically susceptible people. The theory is that when the body fights off an enterovirus infection, the immune response somehow goes awry and starts attacking the insulin-producing cells in the pancreas. However, proving this connection has been challenging because researchers can't always find active virus in the blood of people with Type 1 diabetes.

This exploratory study analyzed blood samples from three groups: people with new-onset Type 1 diabetes, people with established Type 1 diabetes, and healthy controls without diabetes. Researchers used sensitive testing methods to look for enterovirus genetic material and measured the activity of multiple immune genes and immune receptors involved in detecting viruses and triggering antiviral defenses.

The most striking finding was the mismatch between virus detection and immune activation. Using their test conditions, researchers found actual enterovirus genetic material in only one sample from the Type 1 diabetes group—a surprisingly low rate. Despite this minimal virus detection, people with Type 1 diabetes showed significant increases in several immune markers related to viral response.

Two receptors involved in recognizing viruses—TLR3 and TLR7—were significantly elevated in people with Type 1 diabetes. TLR7 levels were highest in those with established disease. Additionally, several interferon-stimulated genes (genes that activate when the body detects a viral threat) showed different expression patterns in the Type 1 diabetes groups compared to healthy controls. These included IFI27 and RSAD2, which were increased in people with new-onset diabetes.

These findings suggest that the immune system in people with Type 1 diabetes may be in a heightened state of readiness to respond to viruses, or may have residual activation from a past viral encounter. This pattern could help explain why Type 1 diabetes develops: even if a specific virus isn't present in the blood at the time of testing, the immune system's viral-response pathways may remain activated in ways that contribute to beta-cell destruction.

The study is exploratory and raises more questions than it answers. Researchers note that detecting virus in blood is just one way viruses might be involved—past infections or infections in other tissues aren't captured by this approach. Future studies will need to clarify whether this immune activation pattern plays a direct role in causing Type 1 diabetes, or whether it's a consequence of diabetes development.

Source: Genes. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.